Home > Insider Trading > Filing (0001140361-13-036145)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070698	Raptor Pharmaceutical Corp	RPTP	Pharmaceutical Preparations (2834)	860883978

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1517790	Louise Suzanne Bruhn	C/O Raptor Pharmaceutical Corp. 5 Hamilton Landing, Suite 160 Novato CA 94949		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-13	2,760	$3.33	2,760	No	4	M	Direct
Common Stock	Disposition	2013-09-13	2,760	$14.07	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock options (right to buy)	Disposition	2013-09-13	2,760	$0.00	2,760	$3.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
72,240	2011-10-11	2021-04-10	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock options (right to buy)	$5.13	2011-12-22	2021-09-21	15,000	15,000	Direct
Common Stock	Stock options (right to buy)	$5.13	2012-03-22	2021-09-21	90,000	90,000	Direct
Common Stock	Stock options (right to buy)	$5.49	2012-12-25	2022-09-24	50,000	50,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-09-21	15,000	15,000	Direct
2021-09-21	90,000	90,000	Direct
2022-09-24	50,000	50,000	Direct

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 28, 2013.
Stock options vest 6/48ths on the six month anniversary of grant date and 1/48th per month thereafter.
Fully vested and exercisable.
Stock options vest 25% quarterly.
The shares listed as owned in column 9 represent the total shares for each respective option. Previous reports reflected aggregate amounts of option shares in column 9. The holding lines included on this Form 4 are included solely to correct the breakdown of shares among various stock options and are not meant to reflect any change in beneficial ownership of option shares other than those reported as a transaction on this Form 4.